» Articles » PMID: 12734645

Effects of the Mycotoxin Ochratoxin A in a Bacterial and a Mammalian in Vitro Mutagenicity Test System

Overview
Journal Arch Toxicol
Specialty Toxicology
Date 2003 May 8
PMID 12734645
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Ochratoxin A (OTA), a mycotoxin produced by several Aspergillus and Penicillium species, is a worldwide contaminant of food and feedstuffs. It is nephrotoxic, immunosuppressive and carcinogenic in several animal species. The mechanism by which OTA acts is not fully understood up to now. Here, OTA was evaluated for mutagenicity in the Salmonella typhimurium assay (Ames assay) and in the HPRT assay with V79 hamster fibroblasts. In the bacterial assay using the strains TA 98, TA 100, TA 1535, TA 1538, TA 102 and TA 104, OTA was not mutagenic at a concentration range from 0.01 to 500 micro M in the presence and absence of an external metabolising enzyme system (rat liver S9 enzyme mix). In V79 fibroblasts, cytotoxicity of OTA was estimated with the neutral red uptake assay. An IC(50) of 11.6 micro M was found in the absence and an IC(50) of 6.4 micro M in the presence of S9 mix. In the subsequent HPRT (hypoxanthine-guanine-phosphoribosyl-transferase) assay with V79 cells the negative result of the bacterial assay was confirmed using OTA in concentrations from 0.1 to 100 micro M. In order to obtain converted OTA metabolites from viable, metabolically competent cells, a preincubation of primary cultured rat hepatocytes with 0.016 to 0.8 micro M OTA was performed. The resulting culture medium, which contained OTA metabolites, was tested in both mutagenicity assays. Again, no mutagenic effect was detected either in the bacterial or in the mammalian test assay. In accordance with several literature data, the present results imply that OTA does not act as direct mutagen. Additionally, the OTA metabolites derived from cultured rat hepatocytes or rat liver S9 mix, also, do not have a mutagenic potency in the test systems used.

Citing Articles

A combination of direct reversion and nucleotide excision repair counters the mutagenic effects of DNA carboxymethylation.

Aloisi C, Escher N, Kim H, Geisen S, Fontana G, Yeo J DNA Repair (Amst). 2022; 110:103262.

PMID: 35030424 PMC: 9232693. DOI: 10.1016/j.dnarep.2021.103262.


Prioritization of Mycotoxins Based on Their Genotoxic Potential with an In Silico-In Vitro Strategy.

Alonso-Jauregui M, Font M, Gonzalez-Penas E, Lopez de Cerain A, Vettorazzi A Toxins (Basel). 2021; 13(10).

PMID: 34679027 PMC: 8540412. DOI: 10.3390/toxins13100734.


Maternal-Fetal Cancer Risk Assessment of Ochratoxin A during Pregnancy.

Woo C, El-Nezami H Toxins (Basel). 2016; 8(4):87.

PMID: 27023600 PMC: 4848614. DOI: 10.3390/toxins8040087.


Safety evaluation of multiple strains of Lactobacillus plantarum and Pediococcus pentosaceus in Wistar rats based on the Ames test and a 28-day feeding study.

Tsai C, Leu S, Huang Q, Chou L, Huang C ScientificWorldJournal. 2014; 2014:928652.

PMID: 25379552 PMC: 4212542. DOI: 10.1155/2014/928652.


Induction of micronuclei by ochratoxin A is a sensitive parameter of its genotoxicity in cultured cells.

Follmann W, Behm C, Degen G Mycotoxin Res. 2013; 23(2):101-9.

PMID: 23605915 DOI: 10.1007/BF02946034.